References

1. 1.
   BRAY F，LAVERSANNE M，SUNG H，et al.Global cancer statistics 2022：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin.2024，74（3）：229-263.
2. 2.
   TAO X，LI T，GANDOMKAR Z，et al.Incidence，mortality，survival，and disease burden of breast cancer in China compared to other developed countries［J］.Asia Pac J Clin Oncol，2023，19（6）：645-654.
3. 3.
   MO M，WANG Z Z，ZHENG Y，et al.Breast cancer in the world and China in 2022：An analysis on epidemic status［J］.Acad J Nav Med Univ，2025，46（4）：497-503.
4. 4.
   GRADISHAR W J，MORAN M S，ABRAHAM J，et al.Breast cancer，version 3.2024，NCCN clinical practice guidelines in oncology［J］.J Natl Compr Canc Netw，2024，22（5）：331-357.
5. 5.
   WEN X L，CAI F Y，CHENG B T，et al.Research progress on pharmacological mechanism of TCM in prevention and treatment of breast cancer［J］.Chin J Exp Tradit Med Form，2025，31（22）：252-263.
6. 6.
   LI H Y，WEN X，REN Y T，et al.Targeting PI3K family with small-molecule inhibitors in cancer therapy：Current clinical status and future directions［J］.Mol Cancer，2024，23（1）：164.
7. 7.
   WANG L J，LI Y L，SI W T，et al.Research progress in traditional Chinese medicine treatment for endocrine resistance in breast cancer［J］.J Oncol Chin Med，2023，5（5）：84-94.
8. 8.
   YI M，LI T Y，NIU M K，et al.Targeting cytokine and chemokine signaling pathways for cancer therapy［J］.Sig Transduct Target Ther，2024，9（1）：176.
9. 9.
   ZHANG R，SUN L M，WANG C，et al.Current status and hotspots of domestic and international research on Chinese medicine for the treatment of breast cancer［J］.Henan Tradit Chin Med，2024，44（9）：1386-1395.
10. 10.
    LEBEAU A，DENKERT C.Aktualisierte WHO-klassifikation der tumoren der mamma：Die wichtigsten änderungen updated WHO classification of tumors of the breast：The most important changes［J］.Pathologe，2021，42（3）：270-280.
11. 11.
    WELLINGS S R，JENSEN H M.On the origin and progression of ductal carcinoma in the human breast2［J］.J Natl Cancer Inst，1973：50（5）：1111-1118.
12. 12.
    PAGE D L，KIDD T E，DUPONT W D，et al.Lobular neoplasia of the breast：Higher risk for subsequent invasive cancer predicted by more extensive disease［J］.Hum Pathol，1991，22（12）：1232-1239.
13. 13.
    ZHANG J.Chinese and western medicine research progress of breast precancerosis lesion［J］.Acta Chin Med，2014，29（1）：9-10.
14. 14.
    MENG B B，RUI R，YIN N N.Meta analysis of TCM in treating breast cancer precancerous lesions［J］.Acta Chin Med，2020，35（2）：433-440.
15. 15.
    SHARMA V R，GUPTA G K，SHARMA A K，et al.PI3K/Akt/mTOR intracellular pathway and breast cancer：Factors，mechanism and regulation［J］．Curr Pharm Des，2017，23（11）：1633-1638．
16. 16.
    HINZ N，JÜCKER ，M.Distinct functions of Akt isoforms in breast cancer：A comprehensive review［J］.Cell Commun Signal，2019，17（1），1-29.
17. 17.
    MAROULAKOU I G，OEMLER W，NABER S P，et al.Akt1 ablation inhibits，whereas Akt2 ablation accelerates，the development of mammary adenocarcinomas in mouse mammary tumor virus （MMTV）-ErbB2/neu and MMTV-polyoma middle T transgenic mice［J］.Cancer Res，2007，67（1）：167-177.
18. 18.
    MARTÍNEZ-SÁEZ O，CHIC N，PASCUAL T，et al.Frequency and spectrum of PIK3CA somatic mutations in breast cancer［J］.Breast Cancer Res，2020，22（1）：45.
19. 19.
    JAHN S W，KASHOFER K，THÜRINGER A，et al.Mutation profiling of usual ductal hyperplasia of the breast reveals activating mutations predominantly at different levels of the PI3K/Akt/mTOR pathway［J］.Am J Pathol，2016，186（1）：15-23.
20. 20.
    CHEN J，SUN J J，WANG Q F，et al.Systemic deficiency of PTEN accelerates breast cancer growth and metastasis［J］.Front Oncol，2022，12：825484.
21. 21.
    BHARUCHA P P，CHIU K E，FRANÇOIS F M，et al.Genetic testing and screening recommendations for patients with hereditary breast cancer［J］.Radio Graphics，2020，40（4）：913-936.
22. 22.
    WANG C，XU Y L，YAO C.Mechanism of chronic oxidative stress on Danlu capsule regulating PI3K-Akt pathway to improve breast cancer precancerous lessions［J］.China J Tradit Chin Med Pharm，2024，39（11）：6049-6053.
23. 23.
    LI L P.Exploration on the molecular mechanism of Shugan Jianpi Jiedu decoction in the prevention and treatment of breastprecancerous lesions based on ER and PI3K/Akt/mTOR pathway［D］.Changsha：Hunan University of Chinese Medicine，2022.
24. 24.
    ZHAO J，PANG T，JIAO J P，et al.Xiaotan Jieyu prescription alleviates breast precancerous lesions through PI3K/Akt signaling pathway［J］.Evid Based Complement Alternat Med，2020，2020：4129461.
25. 25.
    YANG L N.The study of exploring the mechanism of GuBen decoction on triple-negative breast cancer based on PI3K/Akt signaling pathway and epithelial-mesenchymal transition［D］.Guangzhou：Guangzhou University of Chinese Medicine，2021.
26. 26.
    LI X Q，WANG Y，WEI C R，et al.Effect of Rukangyin on expression of PI3K/Akt signal pathway in breast cancer tissue of nude mice［J］.Chin Arch Tradit Chin Med，2019，37（7）：1543-1547.
27. 27.
    HUANG Q，ZHANG F L，LI X L，et al.Effect of Yanghe decoction on human breast cancer MCF-7 cells and its PI3K/Akt signaling pathway［J］.Sichuan J Tradit Chin Med，2019，37（2）：47-50.
28. 28.
    SUN H，SHENG W X，XU C L，et al.The anti-proliferative activity and mechanism exploration of Xiao'ai Jiedu decoction on breast cancer cell lines MDA-MB-231 through PI3K/Akt pathway［J］.J Nanjing Univ Tradit Chin Med，2018，34（2）：173-177.
29. 29.
    MA M，MA Y，ZHANG G J，et al.Eugenol alleviated breast precancerous lesions through HER2/PI3K-Akt pathway-induced cell apoptosis and S-phase arrest［J］.Oncotarget，2017，8（34）：56296-56310.
30. 30.
    WU H T，LIN J，LIU Y E，et al.Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the Akt/mTOR signaling pathway［J］.Phytomedicine，2021，81：153437.
31. 31.
    CHEN X，ZHENG Y，PENG Q，et al.Effects of baicalein on breast cancer cell proliferation via PTEN/PI3K/Akt signaling pathway［J］.Hefei：Acta Univ Med Anhui，2021，56（3）：363-368.
32. 32.
    DOU J W，SHANG R G，LEI X Q，et al.Total saponins of Bolbostemma paniculatum （maxim.） Franquet exert antitumor activity against MDA-MB-231 human breast cancer cells via inhibiting PI3K/Akt/mTOR pathway［J］.BMC Complement Altern Med，2019，19（1）：304.
33. 33.
    ZHANG S B，LI H B.Batisteine inhibits proliferation and induces apoptosis in human breast cancer MCF-7 cells by modulating the PTEN/PI3K/Akt pathway［J］.J Chin Med Mater，2018，41（10）：2431-2434.
34. 34.
    ZHOU R J，CHEN H J，CHEN J P，et al.Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/Akt/mTOR signaling pathway［J］.BMC Complement Altern Med，2018，18（1）：83.
35. 35.
    SUN X，MA X M，LI Q W，et al.Anti-cancer effects of fisetin on mammary carcinoma cells via regulation of the PI3K/Akt/mTOR pathway：In vitro and in vivo studies［J］.Int J Mol Med，2018，42（2）：811-820.
36. 36.
    OH W T，YANG Y S，XIE J，et al.WNT-modulating gene silencers as a gene therapy for osteoporosis，bone fracture，and critical-sized bone defects［J］.Mol Ther，2023，31（2）：435-453.
37. 37.
    XU X F，ZHANG M F，XU F Y，et al.Wnt signaling in breast cancer：Biological mechanisms，challenges and opportunities［J］.Mol Cancer，2020，19（1）：165.
38. 38.
    XIAO Q，CHEN Z X，JIN X Z，et al.The many postures of noncanonical Wnt signaling in development and diseases［J］.Biomed Pharmacother，2017，93：359-369.
39. 39.
    JANDA C Y，WAGHRAY D，LEVIN A M，et al.Structural basis of Wnt recognition by frizzled［J］.Science，2012，337（6090）：59-64.
40. 40.
    BUTLER M T，WALLINGFORD J B.Planar cell polarity in development and disease［J］.Nat Rev Mol Cell Biol，2017，18（6）：375-388.
41. 41.
    YANG W，GARRETT L，FENG D，et al.Wnt-induced Vangl2 phosphorylation is dose-dependently required for planar cell polarity in mammalian development［J］.Cell Res，2017，27（12）：1466-1484.
42. 42.
    ZHUANG X Q，ZHANG H，LI X Y，et al.Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1［J］.Nat Cell Biol，2017，19（10）：1274-1285.
43. 43.
    VAN SCHIE E H，VAN AMERONGEN R.Aberrant Wnt/CTNNB1 signaling as a therapeutic target in human breast cancer：Weighing the evidence［J］.Front Cell Dev Biol，2020，8：25.
44. 44.
    LIU S L，LIU L F，ZENG L H，et al.Study on the mechanism of Astragalus detoxification soup interfering with Wnt/β-catenin pathway to inhibit epithelial mesenchymal transition against breast cancer lung metastasis［J］.Internat J Tradit Chin Med，2023，45（9）：1113-1118.
45. 45.
    WENG Q J，LU W P，CUI S S，et al.Effect of Xihuang pill on the proliferation and dry spheroidization ability of 4T1 cells through Wnt / β-catenin pathwayt［J］.J Beijing Univ Tradit Chin Med，2021，40（9）：968-972.
46. 46.
    HU Y Q，CHEN T X，ZHANG J J，et al.Effects of serum medicated with Trionycis Carapax-Zedoary Turmeric drug pair on MCF-7 human breast cancer cells［J］.Chin Tradit Pat Med，2020，42（10）：2599-2605.
47. 47.
    ZHENG L，ZHENG Q，YU Z，et al.Liuwei Dihuang pill suppresses metastasis by regulating the wnt pathway and disrupting -catenin/T cell factor interactions in a murine model of triple-negative breast cancer［J］.J Tradit Chin Med，2019，39（6）：826-832.
48. 48.
    GUAN H，XIE S，LIU S，et al.Effects of Jiazhu decoction in combination with cyclophosphamide on breast cancer in mice［J］.J Tradit Chin Med，2019，39（5）：642-648.
49. 49.
    DONG J，WANG B C，SHI H，et al.Effects of compound Tubeimu on breast cancer xenografts in nude mice based on Wnt/β-catenin signaling pathway［J］.J Zhejiang Chin Med Univ，2019，43（3）：212-218.
50. 50.
    XU W R，LIN H S，ZHANG Y，et al.Compound Kushen injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway［J］.J Exp Clin Cancer Res，2011，30（1）：103.
51. 51.
    HE G J，HUANG X M，DONG Y，et al.Preliminary investigation on the mechanism of baicalein regulating the effects of nischarin on invasion and apoptosis of human breast cancer cells MCF-7 through Wnt3α/β-catenin pathway［J］.Int Immunopharmacol，2024，143（Pt 1）：113262.
52. 52.
    GHORBANZADEH V，HASSAN ALJAF K A，WASMAN H M，et al.Crocin inhibit the metastasis of MDA-MB-231 cell line by suppressing epithelial to mesenchymal transition through Wnt/β-catenin signalling pathway［J］.Ann Med Surg，2024，86（3）：1401-1407.
53. 53.
    XUE W，HAO J，ZHANG Q P，et al.Chlorogenic acid inhibits epithelial-mesenchymal transition and invasion of breast cancer by down-regulating LRP6［J］.J Pharmacol Exp Ther，2023，384（2）：254-264.
54. 54.
    CAO W F，PAN N S，LI Y.Inhibitory effects and mechanisms of lupeol on proliferation，migration and invasion of human breast cancer MCF-7 cells［J］.Chin Arch Tradit Chin Med，2022，40（10）：156-159.
55. 55.
    WANG F X，YE S H，ZHAO Z J，et al.Anti-tumor effect of piceatannol on triple negative breast cancer cell line MDA-MB-468 and its mechanism［J］.Chin J Exp Tradit Med Form，2021，27（7）：42-48.
56. 56.
    QI X F，QI X，HOU S X.Mechanism of icariin on Wnt/β-catenin pathway mediated epithelial-mesenchymal transition in breast cancer cells［J］.Modern Med J China，2024，26（10）：13-18.
57. 57.
    LING L，XU J Y，ZHAO J F，et al.Progress in prevention and treatment of breast cancer by traditional Chinese medicine targeting Wnt/β-catenin signaling pathway［J］.Chin J Exp Tradit Med Form，2025，31（8）：320-330.
58. 58.
    MAŠEK J，ANDERSSON E R.The developmental biology of genetic Notch disorders［J］.Development，2017，144（10）：1743-1763.
59. 59.
    WANG Z J，ZHAN X Y，MA L Y，et al.Activation of the γ-secretase/NICD-PXR/Notch pathway induces Taxol resistance in triple-negative breast cancer［J］.Biochem Pharmacol，2024，230（Pt 2）：116577.
60. 60.
    KOBIA FM，CASTRO E ALMEIDA L，PAGANONI A J，et al.Novel determinants of NOTCH1 trafficking and signaling in breast epithelial cells［J］.Life Sci Alliance，2025，8（3）：e202403122.
61. 61.
    CHE S Y，YIN D F，GAO H，et al.Mechanism of Ruyanning formula on Notch1 signaling pathway in triple-negative breast cancer bearing nude mice［J］.Chin Arch Tradit Chin Med，2024，42（6）：50-54.
62. 62.
    WU C Y，CHEN M C，SUN Z P，et al.Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch，TGF-β and IL-6 signaling pathways［J］.J Ethnopharmacol，2019，232：145-154.
63. 63.
    WU S T.Effect of Huang Qijiedu decoction on inducing apoptosisof breast cancer cells and expression of Notch1，Jag1 and CyclinD₁［D］.Changsha：Hunan University of Chinese Medicine，2015.
64. 64.
    LI J，GAO F，XUE Z H.Study on the inhibitory effect of isoliquiritin on transplanted breast cancer tumor in mice［J］.Chin J Clin Pharmacol，2023，39（15）：2222-2226.
65. 65.
    YAN X C.Intervention of Jagged1-Notch signaling pathway in thebone metastasis microenvironment of breast cancer byShikonin［D］.Wulumuqi：Xinjiang Medical University，2022.
66. 66.
    PANDEY P，RAMNIWAS S，SEIFELDIN SA，et al.Notch signaling mediated repressive effects of resveratrol in inducing caspase dependent apoptosis in MCF-7 breast cancer cells［J］.Cell Mol Biol ，2024，70（8）：96-103.
67. 67.
    TAN H Y，LI M J，HAN L L，et al.Gypensapogenin Ⅰsuppresses cell proliferation in Triple-Negative breast cancer via triggering the closure of Akt/GSK3β/β-catenin and Notch-1 signaling pathways［J］.J Agric Food Chem，2022，70（17）：5438-5449.
68. 68.
    ZHANG J，YU K，HAN X D，et al.Paeoniflorin influences breast cancer cell proliferation and invasion via inhibition of the Notch-1 signaling pathway［J］.Mol Med Rep，2018，17（1）：1321-1325.
69. 69.
    CAO Y N，YI Y N，HAN C X，et al.NF-κB signaling pathway in tumor microenvironment［J］.Front Immunol，2024，15：1476030.
70. 70.
    SEATON G，SMITH H，BRANCALE A，et al.Multifaceted roles for BCL3 in cancer：A proto-oncogene comes of age［J］.Mol Cancer，2024，23（1）：7.
71. 71.
    STEINBERG G R，HARDIE D G.New insights into activation and function of the AMPK［J］.Nat Rev Mol Cell Biol，2023，24（4）：255-272.
72. 72.
    LI D H，SU Y P，FAN H F，et al.Xihuang pill reversing precancerous lesions of breast cancer in rats and regulating the expression of NF-κB protein［J］.Chin J Gerontol，2021，41（1）：131-134.
73. 73.
    ZHANG Y J，HUANG P W，ZHANG Y T，et al.Effect and mechanism of Xihuang pills on rats with precancerous lesions of breast［J］.China J Chin Mater Med，2023，48（13）：3546-3555.
74. 74.
    CUI Y J，ZHUO Z L，LU W P.Regulatory effect of Huadu Sanyinfang on PI3K/Akt/NF-κB pathway in Triple-negativ breast cancer patients with Qi-deficiency constitution：An exploration based on differential expression of miRNAe［J］.Chin J Exp Tradit Med Form，2021，27（22）：194-200.
75. 75.
    QIN T，YANG Y S，YIN M Y，et al.Berberine induces mitochondrial apoptosis in triple-negative breast cancer MDA-MB-231 cells via SIRT2-mediated NF-κB acetylation［J］.J Guizhou Med Univ，2024，49（5）：658- 664.
76. 76.
    WANG W Y，CHEN R，YANG Y N.Effect of miR-199a-3p/p38 MAPK/NF-κB regulated by sophorae fructus flavonoids on cell proliferation，migration，invasion and secretion of inflammatory factors in breast cancer［J］.J Clin Med Pract，2024，28（4）：1-6，13.
77. 77.
    ZHANG Q X，WEI S J，SUN C G.Inhibition of tubeimoside 1 on proliferation，migration and invasion of triple-negative breast cancer cells through Akt/NF-κB signaling pathway［J］.Beijing J Tradit Chin Med，2024，43（1）：23-26.
78. 78.
    LI J C.Study on the inhibiton of andrographolide on metastaticluminal-like breast cancer by targeting NF-κB signaling pathway［D］.Guangzhou：Guangdong Pharmaceutical University，2021.
79. 79.
    QIU J，ZHANG T，ZHU X，et al.Hyperoside induces breast cancer cells apoptosis via ROS-mediated NF-κB signaling pathway［J］.Int J Mol Sci，2019，21（1）：131.
80. 80.
    SUN X D，ZHU F Y，XIE L X，et al.Effect of diosgenin on Triple-negative breast cancer cells based on NF-κB signaling pathway［J］.Chin Arch Tradit Chin Med，2021，39（6）：112-116，272.
81. 81.
    YANG H，YANG J，ZHENG X，et al.The hippo pathway in breast cancer：The extracellular matrix and hypoxia［J］.Int J Mol Sci，2024，25（23）：12868.
82. 82.
    WEI C R，WANG Y，SONG X L，et al.Effects of medicated serum Rukang Yin and seperated prescriptions on MDA-MB-231 breast cancer cells via Hippo signaling pathway［J］.China J Tradit Chin Med Pharm，2022，37（1）：478-482.
83. 83.
    CAO D.Effeet and mechanism of luteolin on suppressing Triple-Negative breast cancer［D］.Guangzhou：Guangzhou University of Chinese Medicine，2021.
84. 84.
    WU H B，MA Z Q，ZHANG G N，et al.Mechanism of compound Kushen injection inhibiting tumor growthand metastasis in breast cancer model rats by regulating Hippo-YAP signal pathway［J］.J Liaoning Univ Tradit Chin Med，2023，25（11）：72-76.
85. 85.
    PAN Y X，JIAO Z Y，PENG C，et al.Ganoderma lucidum polysaccharide inhibits malignant phenotype of breast cancer via regulation of anti-oxidant factor expressions［J］.Chin Tradit Herb Drugs，2022，53（23）：7440-7448.
86. 86.
    KIM S H，CHOO G S，YOO E S，et al.Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis［J］.Oncol Lett，2021，21（6）：492.
87. 87.
    HOU H T，WANG B B，LI L.Yam bean root regulates breast cancer cell proliferation and apoptosis through MAPK signaling pathway［J］.Chin J Gerontol，2023，43（8）：1943-1947.
88. 88.
    ZHANG H T，QIU Y B，SU R，et al.Ruyanneixiao cream promotes ferroptosis in breast precancerous lesion cells by regulating Nrf2/SLC7A11/GPX4 signaling pathway ［J］.Chin J Exp Tradit Med Form，2025，31（7）：98-107.
89. 89.
    WANG Y L，CHEN F，WANG F.Effect and mechanism of Yanghe Huayan decoction on breast precancerous lesions［J］.Chin Arch Tradit Chin Med，2021，39（3）：44-47，260.
90. 90.
    WANG X N，LIU X F，SUN Y，et al.Effect of Yanghe Huayan decoction on the expressions of p53 and Ki67 in precancerous lesion cells of breast cancer［J］.J Chin Med Pharmacol，2020，48（6）：9-13.